Neurosense Therapeutics will meet with the FDA in early November to discuss plans for a Phase 3 trial to test PrimeC in ALS.

Columnist Dagmar Munn describes the frequent sensation of humming, which was among the early symptoms of her ALS.

A database with long-term ALS respiratory data has been made available to scientists worldwide, with the goal of accelerating research.

Woolsey received three new U.S. patents covering innovations related to ROCK inhibitor Bravyl (oral fasudil), its ...

Juliet lost her husband, Jeff, to ALS in 2020, 19 months after his diagnosis. Together Jeff and Juliet enjoyed being on the water, live music, pets, and traveling. She was his primary caregiver, and ...

Signs of angels come at the most unexpected — yet vital — moments in our lives, columnist Juliet Taylor writes.

The analyses offer evidence for a slowing of functional decline and improved survival outcomes with long-term Radicava ORS by ALS patients.

Neither memantine nor trazodone, two medications approved to treat other conditions, was able to slow disease progression in people with amyotrophic lateral sclerosis (ALS) who took part in a platform ...

Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform ...